Recent insider trading activity from Smith Darren Charlton, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 29, 2026 | Telix Pharmaceuticals Ltd | $TLX | Smith Darren Charlton | Group Chief Financial Officer | M | Ordinary Shares | 1111 | $0.00 | 11,921.0000 | 338,777,049 | 10.28% | 0.00% |
| March 29, 2026 | Telix Pharmaceuticals Ltd | $TLX | Smith Darren Charlton | Group Chief Financial Officer | M | Share Rights | 1111 | $0.00 | 0.0000 | 338,777,049 | 100.00% | 0.00% |